首页|期刊导航|Acta Biochimica et Biophysica Sinica|GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy
GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy
Hanxue Huang Junyan Liu Qi Xiao Chenxue Mao Lei She Lulu Yu Bing Yu Mengrong Lei Ying Gao Baimei He Pinhua Pan Xi Li Jiye Yin Zhaoqian Liu
Acta Biochimica et Biophysica Sinica2025,Vol.57Issue(8):P.1281-1291,11.
Acta Biochimica et Biophysica Sinica2025,Vol.57Issue(8):P.1281-1291,11.DOI:10.3724/abbs.2025013
GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy
摘要
关键词
genome-wide association analysis/non-small cell lung cancer/platinum-based chemotherapy/myelosuppression/EMCN分类
医药卫生引用本文复制引用
Hanxue Huang,Junyan Liu,Qi Xiao,Chenxue Mao,Lei She,Lulu Yu,Bing Yu,Mengrong Lei,Ying Gao,Baimei He,Pinhua Pan,Xi Li,Jiye Yin,Zhaoqian Liu..GWAS study of myelosuppression among NSCLC patients receiving platinum-based combination chemotherapy[J].Acta Biochimica et Biophysica Sinica,2025,57(8):P.1281-1291,11.基金项目
supported by the grants from the National Natural Science Foundation of China(No.82173901) (No.82173901)
the Major Project of the Natural Science Foundation of Hunan Province(Open competition,No.2021JC0002) (Open competition,No.2021JC0002)
the Hunan Province Key Research and Development Plan of China(No.2023SK2007). (No.2023SK2007)